|
| This week's sponsor is Premier Research. | | 
| Where Are Your Unmet Needs? Let's Talk at DIA 2016
Set up a meeting with any of our therapeutic experts to address your analgesia, neuroscience, oncology, pediatrics, and rare disease #researchgoals. Or, better yet, visit us at booth #625! |
Top Stories Friday, June 24, 2016 The increasingly drawn-out play from Sanofi to buy cancer biotech Medivation shows no signs of being settled soon as the biotech’s management continues to push back against the French Big Pharma. Friday, June 24, 2016 CRISPR Therapeutics has raised an additional $38 million as part of its Series B raise, bringing its total to an impressive $140 million--but the company will not be the first to bring the gene editing into the clinic, with this likely to come from Sean Parker’s research outfit. Friday, June 24, 2016 Italian biotech MolMed has been given the backing of European regulators for its new drug that can help blood cancer patients live longer after receiving stem cell transplants to help with their disease. Friday, June 24, 2016 Johns Hopkins University researchers have found a link between cancer immunotherapy drugs and an increased risk of developing rheumatologic disorders--that they expect to only be exacerbated as their use increases. They conducted what’s thought to be the largest published study of patients taking immunotherapies aimed at examining the potential connection between the drug class and these sorts of diseases. Thursday, June 23, 2016 Verona bags £45 million for a COPD trial, Circassia’s flop hits Woodford and Novo A/S names the CEO of its $57 billion fund. And more. Friday, June 24, 2016 Valeant names an accounting head, J&J's longtime IR head retires, and Biogen names an EVP of pharma ops and technology. Plus other hirings, firings and retirings around the industry.
| This week's sponsor is BioSpain. | |  |
| | | Pfizer has completed its acquisition of Anacor Pharmaceuticals, saying "now that Anacor is part of Pfizer, we can accelerate our shared commitment to help patients with inflammatory disease.” Statement GE Healthcare has opened a 500-strong Marlborough, MA, site, committing $27 million to biopharmaceutical innovation and growth ahead of GE’s corporate headquarters move to Boston. Release Cambridge, MA-based Seres Therapeutics has signs a collab with the Massachusetts General Hospital to Identify microbiome therapeutics for obesity. Statement San Francisco’s EpiBiome, a microbiome engineering company, has secured $1 million in debt financing from Silicon Valley Bank. Release | |
|
Resources Sponsored by: SDC Interested in intended use validation of SaaS-based EDC systems? Prefer to discuss rescue study strategies and considerations? How about understanding statistical power for non-statisticians? Vote for your favorite webinar topic to be presented by SDC at DIA on June 28, 2016, 12pm EDT. Cast Your Vote Here to receive your exclusive event invitation and a recording of the webinar after the event. Sponsored by: Covance Al Blunt, MD, Executive Medical Director, Oncology at Covance discusses how the lessons learned from the past decade of developing targeted therapies are relevant to the future development of cancer immunotherapy. Download today! Sponsored by: Veeva Systems Gartner research on short- and long-term strategies for IDMP compliance.
|
|
